ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $282,000 | +34.9% | 78,581 | -5.5% | 0.00% | – |
| Q3 2020 | $209,000 | +67.2% | 83,139 | +213.5% | 0.00% | – |
| Q4 2019 | $125,000 | +9.6% | 26,521 | 0.0% | 0.00% | – |
| Q3 2019 | $114,000 | -52.7% | 26,521 | -79.4% | 0.00% | -100.0% |
| Q4 2018 | $241,000 | -50.8% | 129,045 | -15.7% | 0.00% | 0.0% |
| Q3 2018 | $490,000 | -30.2% | 153,040 | -34.1% | 0.00% | 0.0% |
| Q2 2018 | $702,000 | -22.9% | 232,353 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $911,000 | – | 232,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |